China Universal Asset Management Company’s AbCellera Biologics ABCL Stock Holding History

China Universal Asset Management Company’s Portfolio ABCL Stock Details ABCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$382K	Sell	48,601 -5,197	-10%	-$25.4K	0.02%	287
2026 Q1	$188K	Buy	53,798 +5,021	+10%	+$18.1K	0.01%	357
2025 Q4	$167K	Sell	48,777 -3,604	-7%	-$16.1K	0.01%	366
2025 Q3	$263K	Sell	52,381 -7,568	-13%	-$33.4K	0.02%	307
2025 Q2	$206K	Buy	59,949 +178	+0.3%	+$443	0.02%	308
2025 Q1	$133K	Sell	59,771 -2,858	-5%	-$8.2K	0.01%	343
2024 Q4	$184K	Buy	62,629 +5,955	+11%	+$16.6K	0.02%	334
2024 Q3	$147K	Buy	56,674 +22,128	+64%	+$61.3K	0.02%	323
2024 Q2	$102K	Sell	34,546 -21,760	-39%	-$82.3K	0.01%	300
2024 Q1	$255K	Buy	56,306 +22,740	+68%	+$116K	0.03%	263
2023 Q4	$192K	Buy	33,566 +26,143	+352%	+$121K	0.04%	210
2023 Q3	$34.1K	Buy	7,423 +3,638	+96%	+$22.1K	0.01%	255
2023 Q2	$24.5K	Sell	3,785 -113	-3%	-$771	0.01%	248
2023 Q1	$29.4K	Buy	3,898 +992	+34%	+$9.01K	0.01%	185
2022 Q4	$29.4K	Buy	2,906 +236	+9%	+$2.73K	0.01%	156
2022 Q3	$26K	Buy	+2,670	New	+$29.3K	0.01%	142

Other funds holding ABCL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

China Universal Asset Management Company's ABCL Position: Q2 2026 in Review

China Universal Asset Management Company reduced its AbCellera Biologics (ABCL) stake by 9.7% in Q2 2026, selling an estimated $25.4K and leaving 48,601 shares worth $382K. The position accounts for 0.02% of the portfolio, ranked #287.

China Universal Asset Management Company first reported a position in ABCL in Q3 2022 and has held it in 16 quarters since. 150 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

China Universal Asset Management Company held 48,601 shares of AbCellera Biologics worth $382K as of Q2 2026.
China Universal Asset Management Company sold 5,197 AbCellera Biologics shares in Q2 2026, an estimated $25.4K.
AbCellera Biologics made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #287 holding.
China Universal Asset Management Company first reported a position in AbCellera Biologics in Q3 2022 and has held it in 16 quarters since.
150 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.